Q-omics provides the consensus-scored GOLGA8EP profile across patient tissues and cancer cell-line models. GOLGA8EP expression is associated with patient survival in 13 of 34 cancer types, with the highest sampling consensus in UCS. Among the 18 cancer types available for tumor–normal comparison, GOLGA8EP is differentially expressed in 2, with the highest sampling consensus in KIRC. Additionally, GOLGA8EP RNA expression shows 8,574 significant gene co-expression associations, with the highest sampling consensus in SARC. Together, these results highlight UCS, KIRC, and SARC as cancer lineages where GOLGA8EP shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for GOLGA8EP — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes GOLGA8EP survival associations across molecular data types. GOLGA8EP RNA expression shows survival associations in the most cancer types (13), followed by mutation status (1). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible GOLGA8EP RNA expression–survival associations across cancer types. High GOLGA8EP expression shows unfavorable associations in UCS, KIRC, LIHC, KIRP, CHOL and GBM. The UCS Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify UCS as the clearest survival context for GOLGA8EP RNA expression.
This table summarizes GOLGA8EP tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 2. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for GOLGA8EP. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. GOLGA8EP shows higher tumor expression in KIRC and HNSC. The KIRC box plot shows higher GOLGA8EP RNA expression in tumor versus normal tissue (log2 FC = +0.007, t-test p < 0.001).
This table shows molecular features associated with GOLGA8EP in patient tissues and cancer cell lines. In patient samples, GOLGA8EP shows the broadest associations at the RNA and protein expression levels, with SARC recurring as the lineage with the largest associated feature set.
